Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


Articles published in Scand J Rheumatol

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    May 2018
  1. YOKOE I, Kobayashi H, Kobayashi Y, Giles JT, et al
    Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms.
    Scand J Rheumatol. 2018 May 28:1-7. doi: 10.1080/03009742.2017.1418424.
    PubMed     Text format     Abstract available


  2. SAGELOLI F, Quesada JL, Fautrel B, Salliot C, et al
    Moderate alcohol consumption is associated with increased radiological progression in women, but not in men, with early rheumatoid arthritis: results from the ESPOIR cohort (Etude et Suivi des Polyarthrites Indifferenciees Recentes).
    Scand J Rheumatol. 2018 May 18:1-7. doi: 10.1080/03009742.2018.1437216.
    PubMed     Text format     Abstract available


  3. PEDERSEN JK, Holst R, Primdahl J, Svendsen AJ, et al
    Mortality and its predictors in patients with rheumatoid arthritis: a Danish population-based inception cohort study.
    Scand J Rheumatol. 2018 May 9:1-7. doi: 10.1080/03009742.2017.1420223.
    PubMed     Text format     Abstract available


    April 2018
  4. SILJEHULT F, Arlestig L, Eriksson C, Rantapaa-Dahlqvist S, et al
    Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2018 Apr 27:1-6. doi: 10.1080/03009742.2018.1433232.
    PubMed     Text format     Abstract available


  5. TORRENTE-SEGARRA V, Bergstra SA, Salomon-Escoto K, Da Silva J, et al
    Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients?
    Scand J Rheumatol. 2018 Apr 23:1-4. doi: 10.1080/03009742.2017.1418423.
    PubMed     Text format     Abstract available


  6. HUSBERG M, Bernfort L, Hallert E
    Costs and disease activity in early rheumatoid arthritis in 1996-2000 and 2006-2011, improved outcome and shift in distribution of costs: a two-year follow-up.
    Scand J Rheumatol. 2018 Apr 3:1-6. doi: 10.1080/03009742.2017.1420224.
    PubMed     Text format     Abstract available


    March 2018
  7. FEDELE AL, Petricca L, Tolusso B, Alivernini S, et al
    Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.
    Scand J Rheumatol. 2018 Mar 15:1-9. doi: 10.1080/03009742.2017.1416668.
    PubMed     Text format     Abstract available


  8. ALANI H, Henty JR, Thompson NL, Jury E, et al
    Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjogren's syndrome (secondary Sjogren's syndrome) focusing on autoimmune rheumatic diseases.
    Scand J Rheumatol. 2018;47:141-154.
    PubMed     Text format     Abstract available


    February 2018
  9. DOKOUPILOVA E, Aelion J, Takeuchi T, Malavolta N, et al
    Secukinumab after anti-tumour necrosis factor-alpha therapy: a phase III study in active rheumatoid arthritis.
    Scand J Rheumatol. 2018 Feb 20:1-6. doi: 10.1080/03009742.2017.1390605.
    PubMed     Text format     Abstract available


  10. SCHARMGA A, Geusens P, Peters M, van den Bergh JP, et al
    Structural damage and inflammation on radiographs or magnetic resonance imaging are associated with cortical interruptions on high-resolution peripheral quantitative computed tomography: a study in finger joints of patients with rheumatoid arthritis a
    Scand J Rheumatol. 2018 Feb 20:1-9. doi: 10.1080/03009742.2018.1424234.
    PubMed     Text format     Abstract available


  11. NYSTAD TW, Fenstad AM, Furnes O, Fevang BT, et al
    Predictors for orthopaedic surgery in patients with rheumatoid arthritis: results from a retrospective cohort study of 1010 patients diagnosed from 1972 to 2009 and followed up until 2015.
    Scand J Rheumatol. 2018 Feb 15:1-9. doi: 10.1080/03009742.2017.1397188.
    PubMed     Text format     Abstract available


    January 2018
  12. BRAHE CH, Dehlendorff C, Ostergaard M, Johansen JS, et al
    Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and valida
    Scand J Rheumatol. 2018 Jan 16:1-11. doi: 10.1080/03009742.2017.1376107.
    PubMed     Text format     Abstract available


  13. BAECKLUND E, Backlin C, Ronnelid J, Toes R, et al
    Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2018 Jan 16:1-6. doi: 10.1080/03009742.2017.1376108.
    PubMed     Text format     Abstract available


  14. ZHENG N, Guo C, Wu R
    Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.
    Scand J Rheumatol. 2018 Jan 10:1-3. doi: 10.1080/03009742.2017.1376109.
    PubMed     Text format    


  15. AURELL Y, Andersson M, Forslind K
    Cone-beam computed tomography, a new low-dose three-dimensional imaging technique for assessment of bone erosions in rheumatoid arthritis: reliability assessment and comparison with conventional radiography - a BARFOT study.
    Scand J Rheumatol. 2018 Jan 10:1-5. doi: 10.1080/03009742.2017.1381988.
    PubMed     Text format     Abstract available


  16. GRAM SB, Hess S, Ahlquist P, Hoilund-Carlsen PF, et al
    [(18)F]Sodium fluoride positron emission tomography/computed tomography: a predictor of early rheumatoid arthritis? A case report.
    Scand J Rheumatol. 2018 Jan 10:1-2. doi: 10.1080/03009742.2017.1369153.
    PubMed     Text format    


  17. EBSTEIN E, Ea HK
    Spontaneous resolution of Epstein-Barr virus-induced haemophagocytic lymphohistiocytosis in Still's disease treated by tocilizumab: a case report.
    Scand J Rheumatol. 2018;47:84-85.
    PubMed     Text format    


    October 2017
  18. KUIJPER TM, Luime JJ, Xiong H, de Jong P, et al
    Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study.
    Scand J Rheumatol. 2017 Oct 2:1-7. doi: 10.1080/03009742.2017.1349176.
    PubMed     Text format     Abstract available


    September 2017
  19. KOGA T, Kawashiri SY, Migita K, Sato S, et al
    Comparison of serum inflammatory cytokine concentrations in familial Mediterranean fever and rheumatoid arthritis patients.
    Scand J Rheumatol. 2017 Sep 2:1-3. doi: 10.1080/03009742.2017.1363281.
    PubMed     Text format    


  20. MANGNUS L, van Steenbergen HW, Reijnierse M, Kalvesten J, et al
    Bone mineral density loss in clinically suspect arthralgia is associated with subclinical inflammation and progression to clinical arthritis.
    Scand J Rheumatol. 2017;46:364-368.
    PubMed     Text format     Abstract available


    August 2017
  21. KUETTEL D, Primdahl J, Christensen R, Ornbjerg LM, et al
    Impact of patient-reported flares on radiographic progression and functional impairment in patients with rheumatoid arthritis: a cohort study based on the AMBRA trial.
    Scand J Rheumatol. 2017 Aug 25:1-8. doi: 10.1080/03009742.2017.1329457.
    PubMed     Text format     Abstract available


  22. RASMUSSEN SE, Pfeiffer-Jensen M, Drewes AM, Farmer AD, et al
    Vagal influences in rheumatoid arthritis.
    Scand J Rheumatol. 2017 Aug 2:1-11. doi: 10.1080/03009742.2017.1314001.
    PubMed     Text format     Abstract available


  23. GROSS J, Oubaya N, Eymard F, Hourdille A, et al
    Stressful life events as a trigger for rheumatoid arthritis onset within a year: a case-control study.
    Scand J Rheumatol. 2017 Aug 2:1-2. doi: 10.1080/03009742.2017.1324910.
    PubMed     Text format    


  24. KIADALIRI AA, Kristensen LE, Englund M
    Burden of rheumatoid arthritis in the Nordic region, 1990-2015: a comparative analysis using the Global Burden of Disease Study 2015.
    Scand J Rheumatol. 2017 Aug 2:1-7. doi: 10.1080/03009742.2017.1314002.
    PubMed     Text format     Abstract available


    July 2017
  25. ROERDINK RL, Dietvorst M
    Prognostic factors associated with mortality in patients with arthritis: a descriptive cohort study - comments on the article by Andreasen et al.
    Scand J Rheumatol. 2017;46:331-332.
    PubMed     Text format    


    June 2017
  26. CUPPEN B, Fritsch-Stork R, Eekhout I, de Jager W, et al
    Proteomics to predict the response to tumour necrosis factor-alpha inhibitors in rheumatoid arthritis using a supervised cluster-analysis based protein score.
    Scand J Rheumatol. 2017 Jun 26:1-10. doi: 10.1080/03009742.2017.1309061.
    PubMed     Text format     Abstract available


    May 2017
  27. BERTHOLD E, Mansson B, Gullstrand B, Geborek P, et al
    Tumour necrosis factor-alpha/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis.
    Scand J Rheumatol. 2017 May 9:1-5. doi: 10.1080/03009742.2017.1290822.
    PubMed     Text format     Abstract available


  28. OSTGARD RD, Glerup H, Jurik AG, Kragstrup TW, et al
    Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients.
    Scand J Rheumatol. 2017 May 9:1-5. doi: 10.1080/03009742.2017.1286382.
    PubMed     Text format     Abstract available


  29. KONO M, Yasuda S, Kono M, Atsumi T, et al
    Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis.
    Scand J Rheumatol. 2017 May 8:1-3. doi: 10.1080/03009742.2017.1297482.
    PubMed     Text format    


  30. CHIU YM, Tang CH, Hung ST, Yang YW, et al
    A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study.
    Scand J Rheumatol. 2017;46:236-240.
    PubMed     Text format     Abstract available


  31. HINKKA H, Vaattanen S, Ala-Peijari S, Nummi T, et al
    Effects of cold mist shower on patients with inflammatory arthritis: a crossover controlled clinical trial.
    Scand J Rheumatol. 2017;46:206-209.
    PubMed     Text format     Abstract available


    April 2017
  32. RANNIO T, Asikainen J, Hannonen P, Yli-Kerttula T, et al
    Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
    Scand J Rheumatol. 2017 Apr 3:1-7. doi: 10.1080/03009742.2016.1266029.
    PubMed     Text format     Abstract available


    March 2017
  33. LESUIS N, Verhoef LM, Nieboer LM, Bruyn GA, et al
    Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study.
    Scand J Rheumatol. 2017;46:152-155.
    PubMed     Text format     Abstract available


    February 2017
  34. KOBAYASHI Y, Kobayashi H, Giles J, Yokoe I, et al
    Impact of biological treatment on left ventricular function and morphology in rheumatoid arthritis patients without cardiac symptoms, assessed by cardiac magnetic resonance imaging.
    Scand J Rheumatol. 2017 Feb 20:1-2. doi: 10.3109/03009742.2016.1173722.
    PubMed     Text format    


  35. NGUYEN M, Lindegaard H, Hendricks O, Friis-Moller N, et al
    Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA).
    Scand J Rheumatol. 2017 Feb 1:1-8. doi: 10.1080/03009742.2016.1242774.
    PubMed     Text format     Abstract available


    January 2017
  36. AXELSEN MB, Eshed I, Ostergaard M, Hetland ML, et al
    Monitoring total-body inflammation and damage in joints and entheses: the first follow-up study of whole-body magnetic resonance imaging in rheumatoid arthritis.
    Scand J Rheumatol. 2017 Jan 26:1-10. doi: 10.1080/03009742.2016.1231338.
    PubMed     Text format     Abstract available


  37. LOGSTRUP BB, Masic D, Laurbjerg TB, Blegvad J, et al
    Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study.
    Scand J Rheumatol. 2017 Jan 25:1-9. doi: 10.1080/03009742.2016.1249941.
    PubMed     Text format     Abstract available


  38. BALLESTER C, Grobost V, Roblot P, Pourrat O, et al
    Pregnancy and primary Sjogren's syndrome: management and outcomes in a multicentre retrospective study of 54 pregnancies.
    Scand J Rheumatol. 2017;46:56-63.
    PubMed     Text format     Abstract available


  39. KOH JH, Kwok SK, Lee J, Son CN, et al
    Pain, xerostomia, and younger age are major determinants of fatigue in Korean patients with primary Sjogren's syndrome: a cohort study.
    Scand J Rheumatol. 2017;46:49-55.
    PubMed     Text format     Abstract available


    December 2016
  40. CHIU HY, Wang IT, Huang WF, Tsai YW, et al
    Risk of varicocele in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic disease: a population-based case-control study.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  41. WEITOFT T, Larsson A, Saxne T, Manivel VA, et al
    Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  42. AALTONEN KJ, Joensuu JT, Pirila L, Kauppi M, et al
    Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  43. DOMINGUEZ-MOZO MI, Toledano-Martinez E, Rodriguez-Rodriguez L, Garcia-Montojo M, et al
    JC virus reactivation in patients with autoimmune rheumatic diseases treated with rituximab.
    Scand J Rheumatol. 2016;45:507-511.
    PubMed     Text format     Abstract available


    October 2016
  44. MOLLER-BISGAARD S, Ejbjerg BJ, Eshed I, Horslev-Petersen K, et al
    Effect of a treat-to-target cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  45. SZEREMETA A, Jura-Poltorak A, Komosinska-Vassev K, Zon-Giebel A, et al
    The association between insulin-like growth factor 1 (IGF-1), IGF-binding proteins (IGFBPs), and the carboxyterminal propeptide of type I procollagen (PICP) in pre- and postmenopausal women with rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  46. ADELINO JE, Addobbati C, Pontillo A, Fragoso TS, et al
    A genetic variant within SLC30A6 has a protective role in the severity of rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  47. SHIRI R
    Arthritis as a risk factor for carpal tunnel syndrome: a meta-analysis.
    Scand J Rheumatol. 2016;45:339-46.
    PubMed     Text format     Abstract available


  48. MOREIRA E, Jones A, Oliveira HA, Jennings F, et al
    Effectiveness of insole use in rheumatoid feet: a randomized controlled trial.
    Scand J Rheumatol. 2016;45:363-70.
    PubMed     Text format     Abstract available


  49. PERDAN-PIRKMAJER K, Pirkmajer S, Thevis M, Thomas A, et al
    Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis.
    Scand J Rheumatol. 2016;45:347-55.
    PubMed     Text format     Abstract available


    September 2016
  50. KRABBE S, Bolce R, Brahe CH, Dohn UM, et al
    Investigation of a multi-biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging, computed tomography, ultrasonography, and radiography parameters of inflammation and damage.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  51. MORTENSEN KL, Krogh TP, Jensen-Fangel S, Hauge EM, et al
    Severe acute pancytopaenia in a patient with rheumatoid arthritis complicated by fatal invasive pulmonary aspergillosis.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  52. MORITA T, Shima Y, Kakigano A, Ogata A, et al
    Serum anti-citrullinated protein antibodies of a mother with rheumatoid arthritis pass through the placenta but do not cause arthritis in her neonate.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  53. CHATZIDIONYSIOU K
    Optimizing biological treatments for rheumatoid arthritis.
    Scand J Rheumatol. 2016;45.
    PubMed     Text format     Abstract available


    July 2016
  54. ROME K, Clark H, Gray J, McMeekin P, et al
    Clinical effectiveness and cost-effectiveness of foot orthoses for people with established rheumatoid arthritis: an exploratory clinical trial.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  55. KNEEPKENS EL, van den Oever I, Plasencia CH, Pascual-Salcedo D, et al
    Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  56. MYRTHIANOU E, Zervou MI, Budu-Aggrey A, Eliopoulos E, et al
    Investigation of the genetic overlap between rheumatoid arthritis and psoriatic arthritis in a Greek population.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  57. TUOMINEN S, Leino M, Pirila L, Tuominen R, et al
    Measuring the economic value of morning stiffness: consistency over 1 year.
    Scand J Rheumatol. 2016;45:294-8.
    PubMed     Text format     Abstract available


    June 2016
  58. AUSTAD C, Kvien TK, Olsen IC, Uhlig T, et al
    Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  59. HILLEN MR, Moret FM, van der Wurff-Jacobs K, Radstake T, et al
    Targeting CD1c-expressing classical dendritic cells to prevent thymus and activation-regulated chemokine (TARC)-mediated T-cell chemotaxis in rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  60. OLSSON P, Theander E, Bergstrom U, Jovinge S, et al
    Multiplex cytokine analyses in patients with rheumatoid arthritis require use of agents blocking heterophilic antibody activity.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  61. LEON L, Rodriguez-Rodriguez L, Rosales Z, Gomez A, et al
    Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  62. VOLCHENKOV R, Dung Cao M, Elgstoen KB, Goll GL, et al
    Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


  63. VERGARA F, Rosa J, Orozco C, Bertiller E, et al
    Evaluation of learned helplessness, self-efficacy and disease activity, functional capacity and pain in Argentinian patients with rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  64. SVENSSON B, Andersson M, Forslind K, Ajeganova S, et al
    Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  65. DING S, Duan H, Fang F, Shen H, et al
    CTGF promotes articular damage by increased proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  66. CHRISTENSEN AW, Rifbjerg-Madsen S, Christensen R, Dreyer L, et al
    Non-nociceptive pain in rheumatoid arthritis is frequent and affects disease activity estimation: cross-sectional data from the FRAME study.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  67. KOIVUNIEMI R, Paimela L, Suomalainen R, Leirisalo-Repo M, et al
    Renal diseases in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format    


    February 2016
  68. HALLERT E, Husberg M, Kalkan A, Bernfort L, et al
    Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996-98 and 2006-09.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  69. IWATA T, Ito H, Furu M, Hashimoto M, et al
    Systemic effects of surgical intervention on disease activity, daily function, and medication in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  70. UUTELA T, Kautiainen H, Jarvenpaa S, Hakala M, et al
    Self-rated health in patients with rheumatoid arthritis is associated with health-related quality of life but not with clinical variables.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  71. NORDAL HH, Brun JG, Hordvik M, Eidsheim M, et al
    Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  72. LINDEGAARD HM, Johansen P, Grondal G, Jensen EC, et al
    Doubling the single-dose infusion rate of tocilizumab in rheumatoid arthritis is safe and efficacious.
    Scand J Rheumatol. 2016.
    PubMed     Text format     Abstract available


  73. LEE H, Kim Y, Han K, Oh EJ, et al
    Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Scand J Rheumatol. 2016;45:122-8.
    PubMed     Text format     Abstract available


  74. KOSKENPATO K, Ainola M, Przybyla B, Kouri VP, et al
    Diminished salivary epidermal growth factor secretion: a link between Sjogren's syndrome and autoimmune gastritis?
    Scand J Rheumatol. 2016;45:118-21.
    PubMed     Text format     Abstract available


  75. BIERKARRE H, Harder J, Cuthbert R, Emery P, et al
    Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity.
    Scand J Rheumatol. 2016;45:188-96.
    PubMed     Text format     Abstract available


  76. NUNOKAWA T, Yokogawa N, Shimada K, Enatsu K, et al
    The use of muscle biopsy in the diagnosis of systemic vasculitis affecting small to medium-sized vessels: a prospective evaluation in Japan.
    Scand J Rheumatol. 2016;45:210-4.
    PubMed     Text format     Abstract available


    December 2015
  77. MADSEN SG, Danneskiold-Samsoe B, Stockmarr A, Bartels EM, et al
    Correlations between fatigue and disease duration, disease activity, and pain in patients with rheumatoid arthritis: a systematic review.
    Scand J Rheumatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  78. DIMITROULAS T, Sandoo A, Hodson J, Smith J, et al
    Associations between asymmetric dimethylarginine, homocysteine, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis.
    Scand J Rheumatol. 2015.
    PubMed     Text format     Abstract available


    January 2015
  79. ALTEN R, Holt R, Grahn A, Rice P, et al
    Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone.
    Scand J Rheumatol. 2015;44:354-8.
    PubMed     Text format     Abstract available


  80. HA YJ, Kang EJ, Lee SW, Park YB, et al
    Serum leucine-rich alpha2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
    Scand J Rheumatol. 2015;44:399-403.
    PubMed     Text format     Abstract available


  81. KONTNY E, Janicka I, Skalska U, Maslinski W, et al
    The effect of multimeric adiponectin isoforms and leptin on the function of rheumatoid fibroblast-like synoviocytes.
    Scand J Rheumatol. 2015;44:363-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: